{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T01:12:59Z","timestamp":1657847579852},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>ABSTRACT Objective The aim of this study was to translate and adapt the Newcastle Paediatric Mitochondrial Disease Scale (NPMDS) to Portuguese for use in Brazil. Methods The scale was applied in 20 pediatric patients with mitochondrial disease, in three groups: myopathy (n = 4); Leigh syndrome (n = 8); and encephalomyopathy (n = 8). Scores were obtained for the various dimensions of the NPMDS, and comparisons were drawn between the groups. Results There was a statistically significant difference between the myopathy group and the Leigh syndrome group (p = 0.0085), as well as between the myopathy and encephalomyopathy groups (p = 0.01). Conclusions The translation of the NPMDS, and its adaptation to the socioeconomic and cultural conditions in Brazil, make the NPMDS score useful as an additional parameter in the evaluation and monitoring of pediatric patients with MD in Brazil.<\/jats:p>","DOI":"10.1590\/0004-282x20160137","type":"journal-article","created":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T21:18:47Z","timestamp":1480195127000},"page":"909-913","source":"Crossref","is-referenced-by-count":1,"title":["The Newcastle Pediatric Mitochondrial Disease Scale: translation and cultural adaptation for use in Brazil"],"prefix":"10.1590","volume":"74","author":[{"given":"Gabriela Palhares","family":"Campolina-Sampaio","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Maria de Lima Beliz\u00e1rio Facury","family":"Lasmar","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Silva Vilela","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Gurgel-Giannetti","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"26","key":"ref1","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro S","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.neuro.30.051606.094302","article-title":"Mitochondrial disorders in the nervous system","volume":"31","author":"DiMauro S","year":"2008","journal-title":"Annu. Rev Neurosci"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archneur.63.8.1122","article-title":"Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase (TK2) gene","volume":"63","author":"Oskoui M","year":"2006","journal-title":"Arch Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1212\/WNL.0b013e31829bfe89","article-title":"Mitochondrial encephalomiopathies: fifth years on","volume":"81","author":"Di Mauro S","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s13311-013-0185-6","article-title":"Mitochondrial disease in childhood: nuclear encoded","volume":"10","author":"Goldstein AC","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nurt.2008.07.002","article-title":"How can we treat mitochondrial encephalomyopathies? Approaches to therapy","volume":"5","author":"Horvath R","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng746","article-title":"The desoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA","volume":"29","author":"Mandel H","year":"2001","journal-title":"Nat Genet"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001573-200105000-00008","article-title":"Mitochondria and the heart","volume":"16","author":"Hirano M","year":"2001","journal-title":"Curr Opin Cardiol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2174\/1566524014666141010155317","article-title":"Mitochondrial diseases in childhood","volume":"14","author":"Ardissone A","year":"2014","journal-title":"Curr Mol Med"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.nmd.2006.08.006","article-title":"A scale to monitor progression and treatment of mitochondrial disease in children","volume":"16","author":"Phoenix C","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier FP","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","article-title":"Mitochondrial disease criteria: diagnostic applications in children","volume":"67","author":"Morava E","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"Wild D","year":"2005","journal-title":"Value Health"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/brain\/awt321","article-title":"Disease progression in patients with single, large-scale mitochondrial DNA deletions","volume":"137","author":"Grady JP","year":"2014","journal-title":"Brain"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ymgme.2012.09.023","article-title":"Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease","volume":"107","author":"Blankenberg FG","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbagen.2011.08.006","article-title":"Pyruvate therapy for mitochondrial DNA depletion syndrome","volume":"1820","author":"Saito K","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2014.04.008","article-title":"Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study","volume":"112","author":"Fujii T","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000337161","article-title":"Quality of life in adult patients with mitochondrial myopathy","volume":"38","author":"Orsucci D","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2012.12.012","article-title":"Initial development and validation of a mitochondrial disease quality of life scale","volume":"23","author":"Elson JL","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0883073813481622","article-title":"Mitochondrial disease: a challenge for the caregiver, the family, and society","volume":"28","author":"Sofou K","year":"2013","journal-title":"J Child Neurol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pediatrneurol.2009.11.012","article-title":"Caregiver\u2019s burden and quality of life in mitochondrial disease","volume":"42","author":"Kim KR","year":"2010","journal-title":"Pediatr Neurol"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v74n11\/0004-282X-anp-74-11-0909.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:39:20Z","timestamp":1657845560000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2016001100909&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0004-282X2016001100909"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20160137","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}